Mark Silverman, M.D.
NPI 1780674184 · Specialist · Oceanside, NY
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Mark Silverman, M.D. is a Specialist provider in Oceanside, NY (NPI 1780674184).
Provider details
- NPI number
- 1780674184
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Male
- License
- 174124-1 (NY)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
7,228 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 2,763 | $8 |
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 1,529 | $103 |
| Biopsy of Related Skin Growth, First Growth11102 | 775 | $109 |
| Biopsy of Related Skin Growth, Each Additional Growth11103 | 709 | $58 |
| Destruction of Precancer Skin Growth, 1 Growth17000 | 493 | $52 |
| Shaving of Skin Growth of Body, Arms, Or Legs, 1.1-2.0 Cm11302 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 17 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Triamcinolone Acetonide | 250 | 191 |
| Ketoconazole | 187 | 82 |
| Clobetasol Propionate | 160 | 101 |
| Betamethasone Dipropionate | 113 | 54 |
| Fluorouracil | 72 | 62 |
| Prednisone | 62 | 31 |
| Mometasone Furoate | 40 | 24 |
| Tretinoin | 25 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$280 across 15 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-10-26
- Last updated
- 2007-07-08
Frequently asked questions
- What is Mark Silverman's NPI number?
- Mark Silverman's National Provider Identifier (NPI) is 1780674184, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Mark Silverman's specialty?
- Mark Silverman is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Mark Silverman located?
- Mark Silverman's practice location on file with NPPES is 258 Merrick Rd, Oceanside, NY 11572-1427.
- What is Mark Silverman's phone number?
- The practice phone number listed in the NPPES registry for Mark Silverman is (516) 255-0684.
- Does Mark Silverman accept Medicare?
- Mark Silverman is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Mark Silverman's NPI active?
- Yes — Mark Silverman's NPI (1780674184) is active in the NPPES registry as of the last update on 2007-07-08.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.